UKKi028-C 66540627-1VL

Induced pluripotent stem cells (iPSCs) are adult cells that have been reprogrammed to an embryonic stem cell–like state. The cells can replicate indefinitely or, under controlled conditions, can be differentiated into any other cell type such as nerve, heart or liver cells. Medical researchers are able to use iPS cells to test how different patients might respond to new drugs or to analyse how genetic diseases develop.
The EBiSC stem cell bank, is a collection of human iPS cells available to academic and commercial researchers for use in disease modelling and other forms of stem cell research. The initial collection has been generated from a wide range of donors representing specific disease backgrounds and healthy controls. EBiSC has established many routine procedures for collecting, expanding and characterizing human iPS cell lines. The stem cell bank includes iPSC cell lines derived from neurodegenerative diseases (Alzheimers Disease, Parkinsons Disease, Dementia, Motor Neuron Disease (ALS) - and Huntingtons Disease), eye and heart diseases, and lines from healthy control donors for age and sex matching.
Depositor
Klinikum der Universitat zu Koln
Derivation
Primary cell type: Peripheral blood mononuclear cell
Tissue collection year: 2016
Reprogramming method
Vector type: Non-integrating
Vector: Sendai virus
Gene list:
KLF4
MYC
POU5F1
SOX2
Is the reprogramming vector detectable: No
Merthods used: pcr
Files showing reprogramming vector expressed or silenced: Image / Result
Xeno free conditions: no
Derived under gmp: no
Available as clinical grade: no
Characterization
Analysis of Undifferentiated Cells
Marker expression:
Marker Expressed Immunostaining RT-PCR FACS Enzymatic Assay Expression Profiles
CD30 Yes -
NANOG Yes - -
SOX2 Yes -
OCT 4 Yes - -
DNMT3b Yes -
SSEA-1 Yes -
FOXD3 Yes -
TRA 1-80 Yes - -
SSEA-4 Yes - -
Morphology:
Differentiation potency
Ectoderm:
Ectoderm
In vitro directed differentiation
Marker Expressed
Nestin Yes
Morphology:
Endoderm:
Endoderm
In vitro directed differentiation
Marker Expressed
SOX17 Yes
Morphology:
Protocol or reference:
Trilineage_differentiation_protocol.pdf
Mesoderm:
Mesoderm
In vitro directed differentiation
Marker Expressed
BRACHYURY Yes
Morphology:
Microbiology / Virus Screening
HIV 1: Negative
HIV 2: Negative
Hepatitis B: Negative
Hepatitis C: Negative
Mycoplasma: Negative
Genotyping
Karyotyping
Passage number: 27
Cell line karyotype: no larger chromosomal aberrations to be reported. Chr05: small deletion mosaicism on long arm
Karyotyping method: Molecular karyotyping by SNP array
Image / Result

Additional Cell Line Info,

EBiSC Access Use Agreement (EAUA),

Cell Line Information Pack (CLIP),

Note: EAUA and CLIP must be completed before order fulfillment
Surface coating: Vitronectin
Passage method: Enzyme-free cell dissociation / EDTA
O2 concentration: 20%
CO2 concentration: 5%
Culture medium: other
Culture base medium: StemFlex™
Main protein source: -
Passage Number banked (pre-EBiSC): 24
No. Vials banked (pre-EBiSC): 25
EBiSC is a trademark of Fraunhofer-Gesellschaft
StemFlex is a trademark of Life Technologies Corporation

biological source	human peripheral blood
reprogramming method	Sendai virus
description	age (30-34)
Торговая марка	EBiSC™
gender	female
growth mode	adherent (pluripotent)
application(s)	cell culture | stem cell: suitable
relevant disease(s)	none
shipped in	dry ice
storage temp.	196°C

RIDADR	NONH for all modes of transport
WGK Germany	WGK 3
Flash Point F	Not applicable
Flash Point C	Not applicable